Difference between revisions of "PET Amyloid Biomarker Ctte"

From QIBA Wiki
Jump to: navigation, search
m (PET Amyloid Profile Development)
Line 23: Line 23:
==PET Amyloid Profile Development==
==PET Amyloid Profile Development==
* [[Media:QIBA PET Amyloid Profilea.pdf| QIBA PET Amyloid Profile 2017-04-28]] (BC Vote to Release for Public Comment Form:  )
:*[[Media: QIBA PET Amyloid Profile Edits.xlsx|QIBA PET Amyloid Profile Edits and Open Issues]]
*[[Media:QIBA_AmyloidPET_10Feb2017_1clean_DRAFT.pdf | QIBA PET-Amyloid DRAFT Profile - CLEAN {Dr. Perlman}]] ''February 10, 2017''  (PDF)
*[[Media:QIBA_AmyloidPET_10Feb2017_1clean_DRAFT.pdf | QIBA PET-Amyloid DRAFT Profile - CLEAN {Dr. Perlman}]] ''February 10, 2017''  (PDF)

Revision as of 17:46, 1 May 2017

Co-chairs: Satoshi Minoshima, MD, PhD; Eric S. Perlman, MD; Anne M. Smith, PhD
Secretary: Julie Lisiecki

Project Snapshot

There is a draft Profile, and current outline of the Claim is:

  • SUVr will be the measurand
  • The claim will have two components
1) Cross-sectional: single subject scan
2) Longitudinal: following subject over time

Due to the complexity of having multiple PET Amyloid tracers, a subgroup, the Test-retest Group, has been formed including academics and industry representatives from all of the major PET Amyloid tracer vendors. This group will evaluate the published data on amyloid imaging precision, to determine what level of precision can be claimed in the Profile. The committee’s goal is to have a final draft Profile by December, 2015.

Collaborations: RSNA QIBA is now an affiliate of GAAIN (Global Alzheimer’s Association International Network)

PET Amyloid Meetings/Call Summaries

PET Amyloid Profile Development

Profile Supporting Material

Working Documents

Reference Materials

Presentations and Reports: